Objective. The aim of this study is to describe pregnancy outcomes among women with JIA.
Introduction
JIA is a chronic inflammatory disease of the joints and extra-articular tissue and can lead to long-term damage of the affected areas. Approximately 1020% of adults with juvenile-onset arthritis have moderate to severe functional limitations [1] . Many adults with a history of JIA also have a poor self-image of their body, exhibit anxiety and depression and report reduced social activity [1, 2] . The overall prevalence of juvenile-onset arthritis in women of childbearing age is estimated to be about 12 per 1000 women [1, 3] . Physical impairments and the associated psychological aspects of JIA will have impacts on all aspects of life, including women's reproduction. Compared with their healthy counterparts, women with a history of JIA have a similar desire to have children but are more reluctant to become pregnant; the cited reasons include functional impairment, fear of transmitting JIA to their offspring and physician's advice [4, 5] .
Several studies have investigated the impacts of JIA on women's reproduction and the results are mainly based on self-reported information (questionnaire) with contradictory findings [2, 57] . In a recent study of 75 Norwegian women with JIA, only 43% (n = 32) had a history of pregnancy compared with a rate of 59% in the general population, a 16% reduction in pregnancy rate [7] . Some studies also reported an increased rate of miscarriage or abortion in women with JIA [5] . In contrast, other studies observed similar rates of live birth and miscarriage in women with JIA [6] . With the exception of a reported increase in the risk of Caesarean section (CS) [4] , there is almost no information on neonatal and maternal outcomes of pregnancies among women with JIA.
This study describes pregnancy outcomes among women with a history of JIA and compares their outcomes with the general population using population health data. Understanding the consequences should provide important insights into target areas for health care providers and for counselling women with JIA who are prepared to or have already become pregnant about what to expect.
Methods

Data sources and study population
Two population health datasets were used: the New South Wales (NSW) Perinatal Data Collection (birth data) and the NSW Admitted Patient Data Collection (hospital data). The birth data include all live births or stillbirths of at least 20 weeks gestation or at least 400 g birth weight in NSW. Information collected in the birth data includes demographics, number of previous births and maternal health, pregnancy, labour, delivery and perinatal outcomes. The hospital data cover every inpatient admission in NSW and include demographic and episode-related data. Data from the medical records are coded according to the 10th revision of the International Classification of Diseases Australian Modification (ICD-10-AM) and the affiliated Australian Classification of Health Interventions [8] . Record linkage of birth data and hospital data (both mother and baby) by the Centre for Health Record Linkage [9] was approved by the NSW Population and Health Services Research Ethics Committee. Only de-identified data were made available to researchers. Ethics approval for this specific study was not sought, as the study conforms to the standards established by the National Health and Medical Research Council of Australia for ethical quality review (National Health and Medical Research Council of Australia).
Women in the birth dataset were linked to their medical records in the hospital data from 1 July 2000 to 31 December 2010. Women with an ICD-10-AM code of M08 or M09 in any hospital record in the linked dataset were considered as having had juvenile-onset arthritis and were compared with other women giving birth during the study period. A diagnosis could be recorded in antenatal, birth and postpartum hospital records as well as records prior to pregnancy for women who gave birth during the study period. Up to 20 diagnoses and 20 procedures in each record were used for disease identification in this study.
Ascertainment of risk factors and study outcomes
Variables ascertained from birth data and/or hospital data included maternal age, maternal hypertension (gestational, pre-eclampsia or chronic), maternal diabetes (gestational or pre-gestational), smoking during pregnancy, socio-economic status based on residential postcode (Index of Relative Socio-economic Disadvantage [10] ), interpregnancy interval (interval between first and second births minus gestational age of the second birth), number of births, any abortion or miscarriage (including those before 20 weeks gestation), preterm birth (<37 weeks gestation), infants small for gestational age (birth weight <10th percentile for age and sex [11] ), Apgar score at 5 min (<7), admission to neonatal intensive care unit (NICU >4 h), severe neonatal morbidity (a composite indicator for measuring severe adverse neonatal outcomes [12] ), CS, labour induction, episiotomy, instrumental delivery, antepartum haemorrhage (including placental abruption), pre-eclampsia, postpartum haemorrhage, severe maternal morbidity (a composite indicator for measuring major maternal morbidity [13] ), severe perineal trauma (third-to fourth-degree tear) and length of hospital stay for mother.
Data analysis
Differences between women with and without JIA in age at first birth, abortion rate, length of hospital stay, the first and second pregnancy interval, number of births, proportion of women with more than one birth, etc. were compared using the 2 test, analysis of variance test or
Wilcoxon rank-sum test where appropriate. Logistic regression analysis was used to calculate the odds ratio (OR) for each pregnancy outcome for women with JIA compared with the rest of the birthing population; the lack of independence in study outcomes for multiple pregnancies in the same woman was taken into account using generalized estimating equations (GEEs). The analyses were performed with and without adjusting for known determinants of pregnancy outcomes.
Results
During the study period, 601 659 women had 941 496 births. Of these, 78 births could be attributed to 50 women who had a diagnosis code of juvenile arthritis in the hospital data. Based on the last birth record, the average number of births was 1.8 for women with JIA and 2.2 for the wider birthing population ( Table 1 ). The frequency distribution of pregnancies for the women with and without JIA is shown in Fig. 1 . There were 19 women with JIA who had both first and second birth records in this dataset.
Median age at first birth was similar for women with JIA and the rest of the birthing population (P = 0.07) ( Table 1) . For women with JIA, maternal age for any birth ranged from 16.4 to 42.3 years. Of these 50 women, 6 (12%) had an abortion or miscarriage during the study period; this rate was not different from the 16% observed in the wider birthing population (P = 0.48). With respect to fertility after the first birth, a significantly smaller proportion of women with JIA (48%) had more than one birth than in the wider birthing population (68%, P = 0.003). However, among those who did have more than one birth, there was no difference in first to second pregnancy interval between the two groups (Table 1 , P = 0.67 for median).
Of the 78 JIA pregnancies, 53 (68%) were delivered by either CS (n = 40, 51%) or instrumental delivery (n = 13, 17%). Among the 40 CSs, 31 (78%) were prelabour deliveries. Compared with the wider birthing population, women with JIA had significantly higher rates of pre-eclampsia, postpartum haemorrhage and severe maternal morbidity; their pregnancies were significantly more likely to be delivered by CS or instrumentally even after adjusting for potential confounders including socio-economic status (see footnotes of Table 2 ). Length of stay for the birth admission was longer in women with JIA than in the wider birthing population www.rheumatology.oxfordjournals.org (mean 7.1 vs 4.0 days and median 5 vs 4 days for women with JIA and the general population, respectively; P <0.001 for median). However, no differences between the two groups were observed in the other maternal outcomes: induction of labour, use of epidural, antepartum haemorrhage, episiotomy and third-or fourth-degree tear.
Compared with infants from the wider birthing population, infants from women with JIA were more likely to be born preterm and to be admitted to a NICU and had a higher rate of severe neonatal morbidity (Table 3) . After adjusting for the predictors maternal age at birth, nulliparity, hypertension, diabetes, socio-economic status and smoking during pregnancy, preterm birth remained statistically significantly different between the two groups. The differences in rates of severe neonatal morbidity and admission to a NICU disappeared after adjusting for these predictors and preterm birth. There was no difference in rates of infants small for gestational age or Apgar score <7 at 5 min between the two groups.
Discussion
To our knowledge, this is the first study that specifically investigates relationships between JIA and pregnancy outcomes. The results indicate that women with a history of JIA are at increased risk of preterm delivery, obstetric interventions (CS or instrumental delivery) and maternal complications including pre-eclampsia, postpartum haemorrhage and severe maternal morbidity. Also, compared with the wider birthing population, women with JIA had a longer birth admission and were less likely to become pregnant again. However, the rate of abortion or miscarriage and the interpregnancy interval were similar among all women with a history of birth regardless of their JIA status. Importantly, after controlling for the impact of known determinants of neonatal outcomes, there were no differences between women with JIA and their healthy counterparts in neonatal outcomes except that the rate of preterm birth was higher in women with JIA. For maternal outcomes, other studies of women with RA also reported an elevated risk of pre-eclampsia [14, 15] . In contrast, in their study of first births, Wallenius et al. [16] found that, compared with the general population, 128 women with chronic inflammatory arthritis (including JIA) were not at increased risk of pre-eclampsia, instrumental delivery or postpartum haemorrhage, but were at risk of vaginal bleeding during pregnancy, CS and induction of labour. The reason for the increased risk of pre-eclampsia in our study is unclear and may be related to the use of corticosteroids during pregnancy [17] . Unfortunately, our datasets did not include information on the use of drugs, so we could not explore this possibility. The increased risk of postpartum haemorrhage in our study was not related to the high CS rate, as the size of the risk did not change with additional adjustment for CS in the regression model (data not shown). One explanation could be the use of NSAIDs during pregnancy among the JIA patients. Women might use NSAIDs while they were pregnant despite warnings against doing so. In a US casecontrol study published in 2001, 25% of the meconium samples in the control group were positive for NSAIDs [18] . NSAIDs inhibit prostaglandin synthesis and may lead to increased blood loss during the postpartum period, as prostaglandins are potent vasodilators and increase the permeability of blood vessels [19] . NSAIDs also have an anti-platelet effect and can increase bleeding through that mechanism [20] .
In women with a history of JIA, the high probability of an obstetric intervention during pregnancy is notable. In our study, two-thirds of JIA pregnancies involved either CS (51%) or instrumental delivery (17%). More than 20 years ago, a high CS rate among women with JIA was reported by Ostensen et al. [4] . In that study, 24 of 76 (32%) JIA pregnancies were delivered by CS, and of those 24, 15 (63%) were due to sequelae of JIA. Several studies on women with RA have also reported an increased risk of CS [14, 15, 21] . However, the finding of increased risk of instrumental delivery in women with JIA in our study has not been reported previously. The observed increased risk of obstetric interventions in women with JIA could be a result of their physical impairments. Physical impairments such as chronic or recurrent pain or discomfort and incomplete use of the feet or legs are more pronounced in women with JIA than in women with adult-onset arthritis [1] . The high rate of maternal morbidity is also of concern. Intensive obstetric care should therefore be provided during the antenatal, birth and postpartum periods for women with JIA.
For women with JIA who are planning to have children, the results of neonatal outcomes in our study might provide some comfort, but they should be aware that the study is based on a small number of women with JIA. Although only a small number of women with JIA were included in the study, they were likely to be severe cases, as they were identified from hospital records. Hospital data only record diseases or conditions that require hospitalization or that affect a hospital admission. Other studies also found that risks of birth defect and transfer to the NICU were not increased in women with chronic inflammatory arthritis [16, 21, 22] . However, increased risk of any or spontaneous preterm birth was found in our study and in other studies of women with chronic inflammatory arthritis [16, 21, 22] . Iatrogenic preterm birth might be a result of a timely delivery, albeit prematurely, to avoid stillbirth or complications. In the 1980s and 1990s, women with autoimmune rheumatic diseases were often advised to avoid pregnancy [4] . It is now known that avoiding pregnancy when the diseases are active and continuing to take appropriate medication to keep autoimmune diseases suppressed during pregnancy can reduce the risk of adverse pregnancy outcomes [17] . In a recent study, Viktil et al. [23] reported that the risk of congenital malformation was not increased in children born to mothers or fathers who had received anti-rheumatic drugs 3 months prior to pregnancy and/or during pregnancy. Cooperation between obstetricians and physicians in caring for women with JIA could provide satisfactory pregnancy outcomes. With respect to women's reproduction and foetal loss, contradictory findings to ours were reported in a casecontrol study by Ostensen et al. in 2000 [5] . The authors found that Norwegian women with JIA (n = 126) had reduced fecundity and an increased risk of miscarriage but their fertility was not impaired. In another study of 176 women with JIA who had a mean disease duration of 28 years in the UK in 2002, Packham and Hall [2] reported that women with psoriatic JIA had a significantly higher incidence of miscarriage (33%) than the other JIA groups (11%). In contrast, in two JIA casecontrol studies, Peterson et al.
[6] (44 cases) reported similar pregnancy rates and childbirth rates between two study groups in the USA in 1997 and Wallenius et al. [7] (75 cases) reported similar median interpregnancy interval among all study women in Norway in 2011. Inconsistent results from these studies may be attributed to the small number of JIA cases in each study and/or differences in study methodology, study period and patient selection.
A major limitation of our study is underascertainment of JIA cases from hospital records. Only 50 women were identified from 601 659 women who gave birth over a period of 10.5 years in NSW, representing probably fewer than 10% of the JIA cases. However, they would represent a much higher proportion of those women with active disease during the study period. Many children with arthritis outgrow their illness, and overall the prognosis of JIA is favourable, although this is dependent on the disease type [24] . For example, about 50% of systemiconset JIA cases remit without recurrence in adults. Our study patients would presumably be among those with the most active disease and so might be expected to have the worst pregnancy outcomes. Using all other women who gave birth during the study period as the reference group in our study, a negative result for women with JIA could be reassuring. Other limitations of our study include not knowing the type of JIA, the nature or degree of the women's joint involvement and physical impairments, disease recurrence or use of medications. It is possible that we have underestimated pregnancy losses, with only those resulting in hospital presentation included in our data. Similar rates of pregnancy loss across the study population suggest ascertainment is not higher in women with JIA. With only six cases of pregnancy loss in women with JIA, it is hard to draw strong conclusions.
In summary, women with a history of JIA in our study did not have an increased risk of having infants with adverse neonatal outcomes, but premature birth could be a concern. Also, CS or instrumental delivery was often required, which could be due in part to their physical impairment, so it is recommended that intensive obstetric care be provided during pregnancy. Women with JIA might experience more maternal complications due to the use of medications to suppress disease activity or to the disease itself. Cooperation between obstetricians and family physicians at the pregnancy planning stage and during the pregnancy should reduce these risks.
Rheumatology key messages
. Women with JIA are at increased risk of maternal complications. . Risk of adverse neonatal outcomes among JIA pregnancies is not increased, except preterm birth. . Medical advice and intensive obstetric care for JIA pregnancies should be provided.
